MOUNTAIN VIEW, Calif. — The 2013-2015 West African Ebola virus disease (EVD) epidemic is the largest outbreak in human history. The World Health Organization (WHO) documented 26,648 cases and 11,017 deaths as of May 8, 2015. The outbreak started in Guinea, quickly spreading to neighboring Sierra Leone and Liberia, and eventually spanning nine countries across […]
Oxford Gene Technology (OGT), the molecular genetics company, today announces the launch of the SureSeq™ Myeloid Panel, a highly sensitive next generation sequencing (NGS) panel able to detect mutational changes in 25 genes in one comprehensive assay. The panel replaces the existing procedure of sequential analysis of single genes, to reduce the time and cost […]
TOKYO, Japan and HILDEN, Germany – Hitachi High-Technologies Corporation (TSE:8036) and QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing. Under terms of the agreement, both companies will bring their unique strengths to the collaboration: Hitachi High-Technologies is recognized as […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio with Biotop Oy for Finland. Under the terms of the agreement, SYGNIS has granted Biotop the non-exclusive rights to promote, market and […]
Stratos Genomics Inc. announced today it achieved a major technical milestone last month by demonstrating nanopore sequencing with their proprietary expandable nucleotides (X-NTP™). Stratos’ Sequencing by Expansion technology (SBX™) is an efficient, low-cost DNA preparation method that rescales a DNA target into a longer surrogate polymer. This surrogate, called an Xpandomer™, encodes the sequence information […]
GROTON, Conn. — CURE Innovation Commons announced today that it is welcoming 454 Life Sciences, a Roche Company, as a Founding Sponsor of The Commons, the exciting new office and laboratory space in Southeastern Connecticut. 454 Life Sciences has donated a state-of-the-art DNA sequencing system to The Commons. The GS Junior System can be used […]
PROVO, Utah – Tute Genomics, a leader in cloud-based analytics, interpretation, and reporting for clinical sequencing, today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including internationally recognized Intermountain Healthcare, an integrated network of 22 hospitals and 185 physician […]
Genomics England announced that it will be using technology co-developed in a partnership between the University of Utah and Omicia, and exclusively commercialized through Omicia, to interpret the DNA of Britons as part of the 100,000 Genomes Project, a national effort to hasten creation of diagnostics and treatments that are tailored to a person’s genetic […]
Austin, TX — Bioo Scientific announced that it has developed and optimized automation protocols on the Sciclone® NGS and NGSx Workstations for the NEXTflex™ library preparation kits, including the NEXTflex™ Rapid Directional qRNA-Seq Kit, the NEXTflex™ Rapid Directional RNA-Seq Kit, the NEXTflex™ Rapid RNA-Seq Kit and the NEXTflex™ Rapid DNA-Seq Kit. These fully automated protocols […]
OAKLAND, Calif.–Omicia, the leading clinical genomics company, today announced that it has been selected by Genomics England to provide clinical interpretation services for the 100,000 Genomes Project. For the first phase of the project Illumina will provide sequencing services, while Omicia will provide interpretation and clinical reports. Genomics England leads the UK’s national initiative to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
